BBHVanEck Biotech ETF


$ 167.90 $ -0.25 (-0.15 %)    

Tuesday, 02-Jul-2024 14:00:19 EDT
QQQ $ 486.52 $ 5.06 (1.05 %)
DIA $ 393.25 $ 1.83 (0.47 %)
SPY $ 548.30 $ 3.67 (0.67 %)
TLT $ 90.61 $ 0.70 (0.78 %)
GLD $ 215.57 $ -0.01 (0 %)
$ 168.1808
$ 167.43
$ 168.12 x 200
$ 0.00 x 0
$ 167.43 - $ 168.21
$ 141.88 - $ 173.49
4,334
na
na
$ 0.72
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mifepristone-abortion-pill-access-in-limbo-justice-department-may-ask-supreme-courts-intervention

U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeki...

 womens-reproductive-rights-us-court-preserves-access-to-abortion-pill-for-now-but-with-tighter-rules

A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely u...

 new-york-and-california-prepare-for-potential-mifepristone-ban-in-texas-with-stockpiling-of-alternative-abortion-medications

New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the F...

 attorney-generals-of-over-20-states-sound-alarm-over-suspension-of-abortion-med-approval-devastating-risks-ahead

In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's ...

 us-judge-weighs-nationwide-ban-on-abortion-pills

U.S. District Judge Matthew Kacsmaryk questioned President Joe Biden's administration lawyers on whether the federal regu...

 5-top-etfs-with-exposure-to-biogen

For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA.

 moderna-stock-moves-after-q1-print-technical-levels-for-the-covid-19-vaccine-play

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground.

 3-etfs-for-astrazenecas-39b-alexion-pharmaceuticals-takeover

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weeken...

 a-divergence-has-occurred-in-healthcare

For the first four months of the market’s cornavirus recovery, one of the key themes was the dominance of biotech. 

 3-gilead-heavy-etfs-to-watch-amid-the-astrazeneca-gilead-rumor

In the race to develop a coronavirus vaccine, AstraZeneca (NYSE: AZN) and Gilead Sciences (NASDAQ: GILD) are two of the leading...